Metrics Contract Services

Sponsored Content

Metrics Contract Services is a full service pharmaceutical development and manufacturing organization serving clients worldwide.

Who We Are

Metrics Contract Services is a full service pharmaceutical development and manufacturing organization serving clients worldwide. We deliver proven scientific and operational excellence for oral dosage forms. Today, as a subsidiary of Mayne Pharma Group, we offer clients more resources and capabilities than ever before.

 

Areas of Expertise

 

Pharmaceutical Development and Clinical Trial Materials Manufacturing


We offer comprehensive formulation development services from preclinical through Phase III CTM including: tableting, immediate release, modified release (including controlled/matrix and sustained release), capsule filling, milling, micronizing, enteric coating, spray drying, extrusion, and spheronization. Our facilities and processes are designed to handle potent products, cytotoxic compounds, and controlled substances.

 

 

Analytical Services

Metrics analyzes the physical and chemical characteristics of drug substances and drug products through development and validation of methods, release, and stability testing.

 

Potent Products

Our potent facilities provide total engineered containment through customized, hardwall isolation technologies. Containment is achieved at 30 nanograms per cubic meter of room air; equipment and change parts are dedicated exclusively to potent use. Our facility features independent entry, exit and equipment double airlocks, decontamination showers, dedicated washroom, dedicated equipment storage, and pass through for product/waste.

 

Fast Track First Time In Man (FTIM) Studies

Metrics has successfully delivered materials for over 150 FTIM studies. Our process ensures speed and quality, with a 16-24 week timeline from receipt of well-characterized NCE to shipment to the clinic. Services include stability studies, analytical methods development, and validation.

 

Concept to Commercialization

The parent company of Metrics Contract Services, Mayne Pharma, recently invested $80 million to significantly expand facilities and equipment at its site in Greenville, NC. The new 126,000-sq-ft, oral dose commercial manufacturing facility quadruples the company’s US manufacturing capacity. This means Metrics can offer a more complete “concept to commercialization” solution in one contiguous location for clients, providing larger scale and increased capabilities for seamless scale-up, eliminating the need for site transfers.